McKesson Ponies Up $13M To Settle Drug Claims

Law360, New York (May 5, 2008, 12:00 AM EDT) -- Drug distributor McKesson Corp. has agreed to pay $13.25 million to settle allegations made by six U.S. attorney's offices that the company violated federal reporting provisions in its handling of hydrocodone and alprazolam.

The administrative settlement, which resolves the matter, also calls for a temporary suspension of distribution of the two drugs from two of McKesson’s 31 distribution centers, the company said Friday. McKesson said that it will also tighten its monitoring and reporting procedures for orders for controlled substances.

The California-based company did not admit...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.